Structure-driven development of a biomimetic rare earth artificial metalloprotein.

Thompson, Peter J; Boggs, David G; Wilson, Charles A; Bruchs, Austin T; Velidandla, Uditha; Bridwell-Rabb, Jennifer; Olshansky, Lisa · Proc Natl Acad Sci U S A · 2024

basic_science · Level V

Where this comes from

Abstract

The 2011 discovery of the first rare earth-dependent enzyme in methylotrophic <i>Methylobacterium extorquens</i> AM1 prompted intensive research toward understanding the unique chemistry at play in these systems. This enzyme, an alcohol dehydrogenase (ADH), features a La<sup>3+</sup> ion closely associated with redox-active coenzyme pyrroloquinoline quinone (PQQ) and is structurally homologous to the Ca<sup>2+</sup>-dependent ADH from the same organism. AM1 also produces a periplasmic PQQ-binding protein, PqqT, which we have now structurally characterized to 1.46-Å resolution by X-ray diffraction. This crystal structure reveals a Lys residue hydrogen-bonded to PQQ at the site analogously occupied by a Lewis acidic cation in ADH. Accordingly, we prepared K<sub>142</sub>A- and K<sub>142</sub>D-PqqT variants to assess the relevance of this site toward metal binding. Isothermal titration calorimetry experiments and titrations monitored by UV-Vis absorption and emission spectroscopies support that K<sub>142</sub>D-PqqT binds tightly (<i>K</i><sub>d</sub> = 0.6 ± 0.2 μM) to La<sup>3+</sup> in the presence of bound PQQ and produces spectral signatures consistent with those of ADH enzymes. These spectral signatures are not observed for WT- or K<sub>142</sub>A-variants or upon addition of Ca<sup>2+</sup> to PQQ ⸦ K<sub>142</sub>D-PqqT. Addition of benzyl alcohol to La<sup>3+</sup>-bound PQQ ⸦ K<sub>142</sub>D-PqqT (but not Ca<sup>2+</sup>-bound PQQ ⸦ K<sub>142</sub>D-PqqT, or La<sup>3+</sup>-bound PQQ ⸦ WT-PqqT) produces spectroscopic changes associated with PQQ reduction, and chemical trapping experiments reveal the production of benzaldehyde, supporting ADH activity. By creating a metal binding site that mimics native ADH enzymes, we present a rare earth-dependent artificial metalloenzyme primed for future mechanistic, biocatalytic, and biosensing applications.

Medical subject headings